Clinical Trial Update: The Instant Efficacy and Safety of Alverine in Decreasing Portal Hypertension: an Exploratory Pilot Study [Phase 2]

View source ↗

Summary

This document provides an update on an ongoing Phase 2 exploratory pilot trial evaluating alverine for reducing portal hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Portal Hypertension

Drugs mentioned

• Alverine (Alverine citrate)

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Portal Hypertension | Phase 2 | Status: ENROLLING_BY_INVITATION